4991 related articles for article (PubMed ID: 3208691)
21. [Suppressive effect of rhIL-24 protein on the human A375 cell melanoma in nude mouse].
Zhao XY; Yan S; Han M; Sheng WH; Yang JC
Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Jan; 24(1):54-7. PubMed ID: 18437987
[TBL] [Abstract][Full Text] [Related]
22. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.
Mrowietz U; Schwenk U; Maune S; Bartels J; Küpper M; Fichtner I; Schröder JM; Schadendorf D
Br J Cancer; 1999 Mar; 79(7-8):1025-31. PubMed ID: 10098731
[TBL] [Abstract][Full Text] [Related]
23. [Mitigation of cisplatin toxicity by the complexon tetacin-calcium].
Nikulina LB; Syrkin AB
Eksp Onkol; 1985; 7(4):74-6. PubMed ID: 3930207
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1067-75. PubMed ID: 7730016
[TBL] [Abstract][Full Text] [Related]
25. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
26. Polyethylene glycol-modified concanavalin A as an effective agent to stimulate anti-tumor cytotoxicity.
Ueno T; Ohtawa K; Kimoto Y; Sakurai K; Kodera Y; Hiroto M; Matsushima A; Nishimura H; Inada Y
Cancer Detect Prev; 2000; 24(1):100-6. PubMed ID: 10757129
[TBL] [Abstract][Full Text] [Related]
27. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
[TBL] [Abstract][Full Text] [Related]
28. [Experimental evaluation of synergism of cisplatin with L-lysine-alpha-oxidase].
Pokrovskiĭ VS; Lukasheva EV; Treshchalina EM
Vopr Onkol; 2014; 60(1):90-3. PubMed ID: 24772623
[TBL] [Abstract][Full Text] [Related]
29. Preconditioning chemotherapy with cisplatin enhances the antitumor activity of cytokine-induced killer cells in a murine melanoma model.
Chen J; Huang X; Huang G; Chen Y; Chen L; Song H
Cancer Biother Radiopharm; 2012 Apr; 27(3):210-20. PubMed ID: 22440093
[TBL] [Abstract][Full Text] [Related]
30. Requirement of the acquired immune system in successful cancer chemotherapy with cis-diamminedichloroplatinum (II) in a syngeneic mouse tumor transplantation model.
Taniguchi K; Nishiura H; Yamamoto T
J Immunother; 2011; 34(6):480-9. PubMed ID: 21654518
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-28B acts synergistically with cisplatin to suppress the growth of head and neck squamous cell carcinoma.
Yoshimoto K; Kishida T; Nakano H; Matsui M; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Takeuchi M; Hisa Y; Mazda O
J Immunother; 2011 Mar; 34(2):139-48. PubMed ID: 21304406
[TBL] [Abstract][Full Text] [Related]
32. Effect of oxoplatinum and CBDCA on renal functions in rats.
Láznícková A; Semecký V; Láznícek M; Zubr V; Koksál J; Kvĕtina J
Neoplasma; 1989; 36(2):161-9. PubMed ID: 2654665
[TBL] [Abstract][Full Text] [Related]
33. Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells.
Sun LX; Lin ZB; Duan XS; Lu J; Ge ZH; Li XJ; Li M; Xing EH; Jia J; Lan TF; Li WD
J Pharm Pharmacol; 2011 May; 63(5):725-35. PubMed ID: 21492175
[TBL] [Abstract][Full Text] [Related]
34. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
35. [Human melanoma strains transplantable into athymic mice and rats].
Revazova ES; Solov'ev IuN; Litvinova LV; Kochetkova OD
Biull Eksp Biol Med; 1985 Apr; 99(4):481-3. PubMed ID: 3986377
[TBL] [Abstract][Full Text] [Related]
36. Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.
Wolf M; Eskerski H; Bauder-Wüst U; Haberkorn U; Eisenhut M
Melanoma Res; 2006 Dec; 16(6):487-96. PubMed ID: 17119449
[TBL] [Abstract][Full Text] [Related]
37. GMDP augments antitumor action of the CP/TNFalpha combination in vivo.
Petrova EE; Simonova MA; Komaleva RL; Britsina MV; Andronova TM; Nesmeyanov VA; Valyakina TI
Biomed Pharmacother; 2010 Apr; 64(4):240-8. PubMed ID: 19932583
[TBL] [Abstract][Full Text] [Related]
38. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D
Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088
[TBL] [Abstract][Full Text] [Related]
39. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine.
Dennis JW; Koch K; Yousefi S; VanderElst I
Cancer Res; 1990 Mar; 50(6):1867-72. PubMed ID: 2106389
[TBL] [Abstract][Full Text] [Related]
40. Resistance to intravenous tumor metastases in the athymic nude mouse: a paradoxic response.
Richie JP; McDonald J; Gittes RF
Surgery; 1981 Aug; 90(2):214-20. PubMed ID: 7256537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
